Virotech International Inc. (VTI) is located in the high technology biotech corridor of Maryland, providing state-of-the art contract research services and products to the scientific community in the field of biotechnology. Equipped with latest advanced automated and robotic platforms, VTI acts as a core facility providing services for functional genomics and proteomics. The firm's services and products are supported by highly experienced management and technical staff. VTI has acquired expertise for several complimentary services under one roof, for example LCM, library construction and screening, microarray analysis, DNA sequencing, protein identification by mass spectroscopy and comparative 2-D gel electrophoresis. This permits provision of cost effective, high quality and reliable services with a high degree of confidence. VTI also offers immuno-diagnostic products for rapid, accurate, reliable and cost effective detection of HIV & HCV in blood, serum and plasma samples. Companys new and highly improved diagnostic products are currently marketed through distributors in countries such as India, Turkey, Dominican Republic, Azerbaijan, Ghana, Kenya, Ethiopia, South Africa, Malaysia, and Indonesia. VTI is collaborating with leading national and international pharmaceutical companies and research institutes in the areas of targeted drug delivery and assay development for early detection of highly virulent biological agents. VTI has developed novel technologies in the field of genomics that are under the process of patenting and marketing. The Current focus of the company is to provide support for functional Genomics & Proteomics as a Core Research Facility and develop molecular diagnostic products for rapid detection of wide range of infectious diseases
